Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 10/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.34 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25270378 | 0.88 | FAAH (0.34) | FFAR1FFAR4 | |
| SCHEMBL3345157 | 0.78 | ACACB (0.45) | ACACBFFAR1FFAR4 | |
| SCHEMBL4062990 | 0.75 | ACACB (0.43) | ACACBFFAR1FFAR4 | |
| SCHEMBL8983717 | 0.75 | GRIN2D (0.37) | ACACBFFAR1 | |
| SCHEMBL28176135 | 0.75 | ACACB (0.39) | ACACBFFAR1 | |
| SCHEMBL25276656 | 0.74 | MMP12 (0.36) | ACACBFFAR1MMP12MMP13 | |
| SCHEMBL28047915 | 0.74 | FFAR1 (0.36) | FFAR1FFAR4 | |
| SCHEMBL17590559 | 0.74 | ACACB (0.45) | ACACB | |
| SCHEMBL6517725 | 0.73 | IDO1 (0.43) | FFAR1 | |
| SCHEMBL1710488 | 0.73 | NOS3 (0.38) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | Rolic Technologies AG (CH) | 2026-01-27 | — | — | US | disclosed |
| US-20250066666-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2025-02-27 | — | — | US | disclosed |
| EP-4444822-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-118318024-A | Liquid crystal compound | 罗利克技术有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023104545-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2023-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | SCO2, LBR, C1R | ACACB 331/4885FFAR1 714/4885MMP12 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.